13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001850694
Total reported value
$66.9M
$66.9M
3 檔
190.2%
The Q2 2026 SEC filing reveals that Canaan Partners XI LLC held a total portfolio value of $66.9M, covering 3 public equity positions.
During Q2 2026, Canaan Partners XI LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including AEVA, TYRA, BLNK) accounted for 190.2% of total reported equity market value during Q2 2026.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AEVA | Aeva Technologies Inc | Stock-Other | 81.17% | -5.69% | — | |
| 2 | TYRA | Tyra Biosciences Inc | Stock-Other | 18.82% | +5.69% | — | |
| 3 | BLNK | Blink Charging Co | Stock-Other | — | +0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AEVA | Aeva Technologies Inc | +18.9% | — | Unchanged |
| 2 | BLNK | Blink Charging Co | 0% | — | Unchanged |
| 3 | TYRA | Tyra Biosciences Inc | -18.9% | — | Unchanged |
According to official SEC Form 13F filings, Canaan Partners XI LLC reported a total U.S. public equity portfolio value of $66.9M across 3 disclosed positions in Q2 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
During Q2 2026, Canaan Partners XI LLC's top holdings by market value included AEVA (81.2%)、TYRA (18.8%)、BLNK (0.0%). The largest single position, AEVA, represented 81.2% of total portfolio value.
In Q2 2026, Canaan Partners XI LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.